Microbot Medical Inc. (MBOT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 600K 1.2M 1.8M Q4 '10: 1.4M Q1 '11: 1.4M Q2 '11: 1.4M Q3 '11: 1.4M Q4 '11: 1.2M Q1 '12: 1.6M Q2 '12: 1.7M Q3 '12: 1.7M Q4 '12: 1.4M Q1 '13: 1M Q2 '13: 1M Q3 '13: 1.1M Q4 '13: 935.7K Q1 '14: 675.1K Q2 '14: 635.6K Q3 '14: 393.2K Q4 '14: 1.2M Q1 '15: 1.2M Q2 '15: 1M Q3 '15: 971.2K Q4 '15: 117.2K Q1 '16: 119.3K Q2 '16: 118.5K Q3 '16: 114.2K Q2 '11 Q1 '12 Q4 '12 Q3 '13 Q2 '14 Q1 '15 Q4 '15 Q3 '16

Gross Profit TTM

0 500K 1M 1.5M Q4 '10: 1.3M Q1 '11: 1.2M Q2 '11: 1.2M Q3 '11: 1.1M Q4 '11: 1M Q1 '12: 1.4M Q2 '12: 1.4M Q3 '12: 1.4M Q4 '12: 1.1M Q1 '13: 750K Q2 '13: 769.6K Q3 '13: 816.6K Q4 '13: 886.6K Q1 '14: 921.5K Q2 '14: 881.5K Q3 '14: 853.9K Q1 '11 Q3 '11 Q1 '12 Q3 '12 Q1 '13 Q3 '13 Q1 '14 Q3 '14

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q4 '10: -29.4M Q1 '11: -29.3M Q2 '11: -29.3M Q3 '11: -28.5M Q4 '11: -28.1M Q1 '12: -25.9M Q2 '12: -24.2M Q3 '12: -23.1M Q4 '12: -21.9M Q1 '13: -22.8M Q2 '13: -23.7M Q3 '13: -25.3M Q4 '13: -28.1M Q1 '14: -28.7M Q2 '14: -30.4M Q3 '14: -30.1M Q4 '14: -30.9M Q1 '15: -33M Q2 '15: -34.3M Q3 '15: -38M Q4 '15: 915K Q1 '16: 10.2M Q2 '16: 19.6M Q3 '16: 28.9M Q4 '16: -8.2M Q1 '17: -9.7M Q2 '17: -11.1M Q3 '17: -11.6M Q4 '17: 5.3M Q1 '18: 5M Q2 '18: 4.4M Q3 '18: 3.8M Q4 '18: -7.2M Q1 '19: -7.6M Q2 '19: -7.3M Q3 '19: -7.3M Q4 '19: -7.2M Q1 '20: -7.5M Q2 '20: -7.8M Q3 '20: -8.4M Q4 '20: -9.1M Q1 '21: -9.3M Q2 '21: -9.9M Q3 '21: -10M Q4 '21: -11.4M Q1 '22: -12.1M Q2 '22: -13.2M Q3 '22: -14.2M Q4 '22: -13.3M Q1 '23: -13M Q2 '23: -11.8M Q3 '23: -10.9M Q4 '23: -9.9M Q1 '24: -9.3M Q2 '24: -9.5M Q3 '24: -10.3M Q4 '24: -11.6M Q1 '25: -12.3M Q2 '25: -13.5M Q3 '25: -14M Q4 '25: -14.7M Q1 '26: -16M Q2 '26: -18.5M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-45M -30M -15M 0 15M 30M 45M Q4 '10: -25.2M Q1 '11: -24.9M Q2 '11: -24.3M Q3 '11: -23.1M Q4 '11: -21.3M Q1 '12: -25.8M Q2 '12: -20.9M Q3 '12: -32.9M Q4 '12: -28.5M Q1 '13: -24.7M Q2 '13: -31.4M Q3 '13: -22.2M Q4 '13: -26.4M Q1 '14: -27.6M Q2 '14: -33.9M Q3 '14: -29.5M Q4 '14: -32.7M Q1 '15: -34.5M Q2 '15: -30.8M Q3 '15: -37.7M Q4 '15: -921K Q1 '16: 8.2M Q2 '16: 16.5M Q3 '16: 25.4M Q4 '16: -8.8M Q1 '17: -9.8M Q2 '17: -13.2M Q3 '17: -13.7M Q4 '17: -7.6M Q1 '18: -7.8M Q2 '18: -6.2M Q3 '18: -6.7M Q4 '18: -7.3M Q1 '19: -7.7M Q2 '19: -7.4M Q3 '19: -7.5M Q4 '19: -7.2M Q1 '20: -7.5M Q2 '20: -7.8M Q3 '20: -8.4M Q4 '20: -9.2M Q1 '21: -9.4M Q2 '21: -10M Q3 '21: -10.1M Q4 '21: -11.3M Q1 '22: -12.1M Q2 '22: -13.1M Q3 '22: -14M Q4 '22: -13.2M Q1 '23: -12.8M Q2 '23: -11.6M Q3 '23: -10.6M Q4 '23: -10.7M Q1 '24: -10.3M Q2 '24: -10.4M Q3 '24: -11.2M Q4 '24: -11.4M Q1 '25: -11.7M Q2 '25: -12.7M Q3 '25: -13.1M Q4 '25: -13.1M Q1 '26: -14.2M Q2 '26: -16.3M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q2 '11: -23.9M Q3 '11: -21.7M Q4 '11: -22.1M Q1 '12: -20.3M Q2 '12: -19.6M Q3 '12: -20.2M Q4 '12: -19.9M Q1 '13: -20.9M Q2 '13: -19.6M Q3 '13: -21.4M Q4 '13: -23.3M Q1 '14: -23.2M Q2 '14: -27.2M Q3 '14: -27.9M Q4 '14: -27.4M Q1 '15: -29.8M Q2 '15: -29.6M Q3 '15: -30.1M Q4 '15: -765K Q1 '16: 7.8M Q2 '16: 15.4M Q3 '16: 22.2M Q4 '16: -786K Q1 '17: -1.3M Q2 '17: -2.6M Q3 '17: -3.6M Q4 '17: -4.9M Q1 '18: -5.3M Q2 '18: -5.2M Q3 '18: -5.2M Q4 '18: -5.3M Q1 '19: -6.8M Q2 '19: -6M Q3 '19: -6M Q4 '19: -6.5M Q1 '20: -6.1M Q2 '20: -6.9M Q3 '20: -7.3M Q4 '20: -7.3M Q1 '21: -6.9M Q2 '21: -7.9M Q3 '21: -8.3M Q4 '21: -9.4M Q1 '22: -10.4M Q2 '22: -11.2M Q3 '22: -12M Q4 '22: -11.5M Q1 '23: -11.7M Q2 '23: -10.5M Q3 '23: -9.2M Q4 '23: -8.5M Q1 '24: -7.8M Q2 '24: -7.9M Q3 '24: -9M Q4 '24: -8.8M Q1 '25: -9.3M Q2 '25: -9.9M Q3 '25: -11M Q4 '25: -13M Q1 '26: -15.2M Q2 '26: -17.6M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q2 '11: -24.4M Q3 '11: -22.2M Q4 '12: -19.9M Q1 '13: -21.3M Q2 '13: -22.1M Q3 '13: -26M Q4 '13: -28M Q1 '14: -27.8M Q2 '14: -29.8M Q3 '14: -28.6M Q4 '14: -28.3M Q1 '15: -30.6M Q2 '15: -30.7M Q3 '15: -30.4M Q4 '15: -767K Q1 '16: 7.6M Q2 '16: 14.8M Q3 '16: 22.2M Q4 '16: -811K Q1 '17: -1.3M Q2 '17: -2.7M Q3 '17: -3.6M Q4 '17: -4.9M Q1 '18: -5.5M Q2 '18: -5.5M Q3 '18: -5.5M Q4 '20: -7.3M Q1 '21: -6.9M Q2 '21: -7.9M Q3 '21: -8.4M Q4 '21: -9.4M Q1 '22: -10.4M Q2 '22: -11.3M Q3 '22: -12.1M Q4 '22: -11.6M Q4 '24: -8.9M Q1 '25: -9.3M Q2 '25: -9.9M Q3 '25: -11M Q4 '25: -13.1M Q1 '26: -15.4M Q2 '26: -17.9M Q3 '13 Q1 '15 Q3 '16 Q1 '18 Q3 '21 Q4 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q1 '21: 7.1M Q2 '21: 7.1M Q3 '21: 7.1M Q1 '22: 7.1M Q2 '22: 7.1M Q3 '22: 7.1M Q1 '23: 8M Q2 '23: 9.2M Q3 '23: 11.7M Q1 '24: 14.1M Q2 '24: 14.8M Q3 '24: 16.5M Q1 '25: 31.1M Q2 '25: 36.5M Q3 '25: 48.1M Q1 '26: 67.2M Q2 '26: 67.2M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '10: -2.05 Q1 '11: -1.96 Q2 '11: -1.87 Q3 '11: -1.74 Q4 '11: -1.50 Q1 '12: -1.53 Q2 '12: -1.21 Q3 '12: -1.44 Q4 '12: -1.03 Q1 '13: -0.75 Q2 '13: -0.93 Q3 '13: -0.56 Q4 '13: -0.62 Q1 '14: -0.59 Q2 '14: -0.66 Q3 '14: -0.53 Q4 '14: -0.55 Q1 '15: -2.03 Q2 '15: -2.88 Q3 '15: -3.91 Q4 '15: -3.84 Q1 '16: -2.23 Q2 '16: -1.17 Q3 '16: -0.18 Q4 '16: 0.39 Q1 '17: 0.44 Q2 '17: 0.36 Q3 '17: -0.01 Q4 '17: -1.01 Q1 '18: -1.55 Q2 '18: -2.12 Q3 '18: -2.27 Q4 '18: -2.38 Q1 '19: -2.36 Q2 '19: -2.06 Q3 '19: -1.90 Q4 '19: -1.71 Q1 '20: -1.54 Q2 '20: -1.44 Q3 '20: -1.35 Q4 '20: -1.29 Q1 '21: -1.32 Q2 '21: -1.41 Q3 '21: -1.42 Q4 '21: -1.59 Q1 '22: -1.70 Q2 '22: -1.84 Q3 '22: -1.97 Q4 '22: -1.81 Q1 '23: -1.72 Q2 '23: -1.48 Q3 '23: -1.20 Q4 '23: -1.08 Q1 '24: -0.89 Q2 '24: -0.81 Q3 '24: -0.80 Q4 '24: -0.74 Q1 '25: -0.65 Q2 '25: -0.58 Q3 '25: -0.45 Q4 '25: -0.29 Q1 '26: -0.26 Q2 '26: -0.24 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.